Brian Banks
Psychiatric/Mental Health · Pembroke, MANPI 1780067645
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Neuronetics, Inc. accounts for 93.2% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $23,527, more than ten times the $676 reported in 2021. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $180.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$43K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$327
- Johnson & Johnson$218
- Takeda Pharmaceuticals U.S.A., Inc.$217
- Lundbeck LLC$214
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$24,85853%
- Travel & lodging$14,95932%
- Food & beverage$6,75614%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 58 | $43,453 |
| AbbVie(2 entities) | 88 | $1,165 |
| Otsuka America Pharmaceutical, Inc. | 28 | $327 |
| Johnson & Johnson | 9 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $217 |
| Lundbeck LLC | 13 | $214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $184 |
| Corium, LLC | 9 | $149 |
| Supernus Pharmaceuticals, Inc. | 6 | $133 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Ironshore Pharmaceuticals Inc. | 2 | $99 |
| Tris Pharma Inc | 5 | $80 |
| Sunovion Pharmaceuticals Inc. | 4 | $73 |
| Tempus AI, Inc | 2 | $44 |
| Neurocrine Biosciences, Inc. | 3 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| Alkermes, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$42,747
How this compares
$46,620 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 11 | $15,548 |
| Methylphenidate ErMethylphenidate Hcl | 15 | $1,339 |
| Lamotrigine | 16 | $133 |
| Lorazepam | 16 | $79 |
| Trazodone Hcl | 14 | $74 |
| Clonazepam | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $327 | $15,54811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
Other psychiatric/mental health in Pembroke
- Rachael FortunatoPembroke$6K
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.